How to Buy Trevi Therapeutics Stock
Trevi Therapeutics Inc
Trevi Therapeutics, Inc. , a clinical-stage biopharmaceutical company, focuses on the development and commercialization of Haduvio to treat serious neurologically mediated conditions.
Trevi Therapeutics stock last closed at $6.07, up 0.83% from the previous day, and has increased 106.46% in one year. It has overperformed other stocks in the Biotechnology industry by 1.83 percentage points. Trevi Therapeutics stock is currently +163.91% from its 52-week low of $2.30, and -17.86% from its 52-week high of $7.39.
As of Apr 22, 2025, there are 96.68M TRVI shares outstanding. The market cap of TRVI is $586.86M. In the last 24 hours, 1.02M TRVI shares were traded.
How to Buy Trevi Therapeutics Stock
Not sure how to invest in Trevi Therapeutics stock? Here's how.
- Decide where to buy Trevi Therapeutics stock: You need to choose an online brokerage, but don't worry - we've tried dozens of online stock brokerages and apps to help you figure out where to buy Trevi Therapeutics stock.
- Sign up for a brokerage account: Sign up for 0% fee trading with the highest-rated brokerage we've found.
- Fund your investment account: Pick your payment method and add your information.
- Evaluate Trevi Therapeutics stock: The Trevi Therapeutics ticker symbol is TRVI. Is Trevi Therapeutics stock a good investment? Should you buy shares of TRVI? How do TRVI's underlying business fundamentals look? Do top analysts think Trevi Therapeutics is a good buy? Why has TRVI's stock price moved recently? (Hint: Our stock research website can help you decide if TRVI is a good stock to buy).
- Make your TRVI buy order: Decide if you will purchase TRVI shares at the current market price or use a limit order to buy TRVI shares at a specific price.
- Keep an eye on your TRVI investment: Create a watchlist to keep tabs on your investment in Trevi Therapeutics shares.
Step 1: Decide where to buy Trevi Therapeutics stock
You need an online brokerage account in order to access the NASDAQ market and buy TRVI shares.
Our recommended brokerage: eToro
We believe that eToro is the best online stock brokerage. eToro gives you:
- Invest in stocks with zero commissions: Invest without commissions.
- Buy fractional shares: Even if you can't afford a full share, you can still purchase the stock.
- Access to world markets: From Technology to Industrials, New York to Shanghai (for US users, only US stocks are available) — you can fill your portfolio with stocks from the world's leading exchanges.
- Social investing: eToro boasts a community of more than 20 million users worldwide. Talk to, learn from, and copy the unique crypto portfolios of other investors.
- Security: eToro is a regulated and licensed fintech leader.
- Buy other assets: Such as ETFs and cryptocurrencies.
Get $10 towards your share purchase by creating an account with eToro now. This offer is only for US users.
Open eToro AccountStep 2: Sign up for a brokerage account
Now that you've chosen your brokerage, you'll need to fill out some personal info so you are able to buy TRVI stock today.
How to Start a New Account on eToro
- Click here to get started.eToro is a multi-asset investment platform. The value of your investments may go up or down. Your capital is at risk.
- Provide your personal details to open a new trading account.
- Submit your application by pressing the "Create Account" button. Get started with eToro today
Step 3: Fund your investment account
Now that you've filled out your info on investing apps, you can securely and quickly fund your account:
Watch this video walkthrough if you need help depositing funds into your investment account.
Step 4: Evaluate Trevi Therapeutics stock
Once you have selected the best place to buy Trevi Therapeutics stock, it's absolutely critical to evaluate their stock prior to investing, so you actually understand the risk as well as the upside.
Trevi Therapeutics Numbers
TRVI Fundamentals
WallStreetZen was created to help everyday investors do better fundamental analysis quickly.
You can see all of the due diligence checks on TRVI's stock page.
Is TRVI stock undervalued?
Analysts use many financial metrics, analyses, models, and charts to gauge TRVI's fair value.
Using relative valuations metrics:
- TRVI may be overvalued based on its P/B ratio of 5.89x, relative to Biotechnology industry P/B ratio of 4.16x
You can do more valuation analysis on TRVI's stock here.
A quick look at TRVI Financials
Positive Health Checks:
- TRVI has a low debt to equity ratio of 0.11.
- There are more short-term assets than long-term liabilities on the TRVI balance sheet.
- There are more short-term assets than short-term liabilities on the TRVI balance sheet.
- TRVI has cash burn of 38291000. It has sufficient cash and short-term investments to cover this for at least one year.
- TRVI has $107.62M in cash and short term investments. This is sufficient to cover its annual cash burn of $38.29M.
Negative Health Checks:
- Total TRVI debt is higher than 5 years ago, relative to shareholder equity.
Do analysts think it's a good time to buy Trevi Therapeutics stock
Out of 6 Equities analysts who give ratings on TRVI, the consensus analyst rating on TRVI is a Strong Buy
Please keep in mind that analyst forecasts are not recommendations, nor are they financial advice.
Most Recent TRVI Analyst Forecasts
Ryan Deschner, a top 30% analyst from Raymond James upgrades TRVI to a strong buy rating and raises their TRVI price target from $9.00 to $29.00, on Mar 10, 2025.
You can dive deeper into what analysts are forecasting on the Trevi Therapeutics stock forecast page.
TRVI Trading Indicators
Who is buying/selling TRVI?
In the last 12 months, executives and large shareholders at TRVI have bought more shares than they have sold.
Thomas Sciascia, Chief Scientific Officer of TRVI, was the latest TRVI insider to buy. They bought $3,762.33 worth of TRVI stock on Mar 25, 2025.
Research more about who owns TRVI shares here.
Can I rely on TRVI as an income stream?
No, Trevi Therapeutics doesn't provide an income stream by paying out dividends.
What others are saying about TRVI
One of the primary reasons eToro is our top-rated brokerage is because of its social trading community.
Click below to find out what other investors have to say.
Step 5: Make your TRVI buy order
There are two primary order types:
- Market order: A market order is an order to buy or sell a security at the best available price.
Market orders are generally fine for most investors. - Limit order: A limit order allows you to buy or sell a stock at a specific price (or better).
If you want to ensure you're buying or selling at a given price limit, place a limit order.
Press the Open Trade button and your broker will place the order.
If you require more assistance buying stocks on eToro, click the helpful video below:
Step 6: Keep an eye on your TRVI investment
Now that you own some shares in TRVI, you'll want to keep up with your company.
Start a watchlist to track the latest developments regarding your TRVI stock.
TRVI Feed
How to Buy Stock in Trevi Therapeutics
To reiterate, here are the 6 steps to buy stock in Trevi Therapeutics:
- Decide where to buy Trevi Therapeutics stock
- Sign up for a brokerage account
- Fund your investment account
- Evaluate Trevi Therapeutics stock
- Make your TRVI buy order
- Keep an eye on your TRVI investment
If you require a brokerage account, eToro is our recommended venue.
Get Started with eToro TodayIf you want to keep an eye on your investment in Trevi Therapeutics, create a watchlist today.
Trending Stock Buying Guides
FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterInformation is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.